<span style="font-variant: small-caps">l</span>-Buthionine Sulfoximine Detection and Quantification in Polyurea Dendrimer Nanoformulations
<span style="font-variant: small-caps;">l</span>-Buthionine sulfoximine (<span style="font-variant: small-caps;">l</span>-BSO) is an adjuvant drug that is reported to increase the sensitivity of cancer cells to neoplastic agents. Dendrimers are exceptional...
Main Authors: | Pedro Mota, Rita F. Pires, Jacinta Serpa, Vasco D. B. Bonifácio |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-08-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/24/17/3111 |
Similar Items
-
Polyurea Dendrimer Folate-Targeted Nanodelivery of <span style="font-variant: small-caps">l</span>-Buthionine Sulfoximine as a Tool to Tackle Ovarian Cancer Chemoresistance
by: Adriana Cruz, et al.
Published: (2020-02-01) -
The effect of BSO-induced oxidative stress on histologic feature of testis: testosterone secretion and semen parameters in mice
by: Fakhrosadat Sajjadian, et al.
Published: (2014-08-01) -
N-acetylcysteine decreases malignant characteristics of glioblastoma cells by inhibiting Notch2 signaling
by: Jie Deng, et al.
Published: (2019-01-01) -
The design, synthesis and antiplasmodial evaluation of novel sulfoximine-isoxazole hybrids as potential antimalarial agents
by: Jackie L. Mabasa, et al.
Published: (2024-04-01) -
Oxidative damage alters memory consolidation in adult rats
by: Mei-Li Díaz-Hung, et al.
Published: (2011-12-01)